2137 Comparison of two Phase II trials of mFOLFOX6 plus bevacizumab (KSCC0802) and SOX (S-1 and oxaliplatin) plus cetuximab (KSCC1002): First line chemotherapy in colorectal cancer patients with initially unresectable or not optimally resectable liver only metastases. (September 2015) - Oki, E.; Emi, Y.; Miyamoto, Y.; Ogata, Y.; Tokunaga, S.; Shirabe, K.; Beppu, T.; Uchida, S.; Takatsuki, M.; Sakoda, M.; Eguchi, S.; Akagi, Y.; et al.